• PMD5 ANALISIS DEL IMPACTO SANITARIO Y PRESUPUESTARIO POR LA INCORPORACION DEL TEST DE HPV CON GENOTIPIFICACION PARA EL TAMIZAJE PRIMARIO DE CANCER CERVICAL EN UNA POBLACION CERRADA DE UN HOSPITAL UNIVERSITARIO DE LA CIUDAD DE BUENOS AIRES

    Oct 1, 2019, 00:00

  • PNS57 REAL WORLD EVIDENCE LANDSCAPE IN LATIN AMERICA HEALTH CARE DECISION MAKING: EXPLORING UNDERSTANDING, ACCEPTABILITY AND USE

    Oct 1, 2019, 00:00

  • PMU15 A MOBILE PHONE APP HEALTH CARE PROGRAM IN BRAZIL: SELF-REPORTS TO ASSESS DISEASE PREVALENCE

    Oct 1, 2019, 00:00

  • PCV10 EPIDEMIOLOGICAL STUDY DESIGN TO UNDERSTAND CARDIOVASCULAR RISK FACTORS AND TREATMENT IN GENERAL PRACTICE PATIENTS IN LATIN AMERICA

    Oct 1, 2019, 00:00

  • PIN1 COST-EFFECTIVENESS ANALYSIS OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE FOR HIGH RISK PATIENTS IN THE PERSPECTIVE OF BRAZILIAN NIP

    Oct 1, 2019, 00:00

  • PND18 THE RESTORE REGISTRY: A RESOURCE FOR MEASURING AND IMPROVING SPINAL MUSCULAR ATROPHY OUTCOMES

    Oct 1, 2019, 00:00

  • PCN26 IMPACTO DE LAS RECAÍDAS EN LOS PACIENTES COLOMBIANOS CON LINFOMA FOLICULAR

    Oct 1, 2019, 00:00

  • PNS37 REVIEW OF QUALITY AND PERFORMANCE INDICATORS RELATED TO INPATIENT CARE IN SELF-FUNDED HEALTH PLANS

    Oct 1, 2019, 00:00

  • RE3 RELAPSING-REMITTING MULTIPLE SCLEROSIS: COSTS BENEFITS OF EXPANDING COVERAGE FROM A PUBLIC PAYER PERSPECTIVE

    Oct 1, 2019, 00:00

  • PND15 CHARACTERIZATION OF THE ARGENTINE POPULATION WITH AT LEAST 4 MONTHLY MIGRAINE DAYS: RESULTS FROM MIGRAINE VOICE SURVEY

    Oct 1, 2019, 00:00

  • PCN9 ANÁLISIS DE IMPACTO PRESUPUESTAL DE LA DETECCIÓN TEMPRANA DEL CÁNCER DE CUELLO UTERINO EN MUJERES DE 30 A 65 AÑOS MEDIANTE TAMIZACIÓN CON TEST DE VPH Y GENOTIPIFICACIÓN FRENTE CITOLOGÍA CONVENCIONAL, EN COLOMBIA

    Oct 1, 2019, 00:00

  • PNS25 COMPARING THE REMUNERATION OF HOSPITAL NURSES IN COUNTRIES WITH BISMARCK AND BEVERIDGE HEALTH CARE SYSTEMS

    Oct 1, 2019, 00:00

  • PIN25 CALIDAD DE REVISIONES SISTEMATICAS CON EVALUACIONES DE COSTO-EFECTIVIDAD DE LA VACUNA CONTRA ROTAVIRUS DE PAISES LATINOAMERICANOS

    Oct 1, 2019, 00:00

  • PRO5 ASSESSMENT OF COST-EFFECTIVENESS RESULTS FROM ICER ADVANCED THERAPIES MEDICINAL PRODUCTS REVIEWS

    Oct 1, 2019, 00:00

  • PUK6 AN EVALUATION OF THE BRAZILIAN POLICY FOR THE MANAGEMENT OF CHRONIC KIDNEY DISEASE UNDER THE PERSPECTIVE OF THE PUBLIC HEALTH CARE SYSTEM: WAS IT EFFECTIVE?

    Oct 1, 2019, 00:00

  • CN3 SYSTEMATIC REVIEW OF ECONOMIC EVALUATIONS OF COLORECTAL CANCER SCREENING STRATEGIES FOR THE EARLY DETECTION OF COLORECTAL CANCER IN THE GENERAL POPULATION

    Oct 1, 2019, 00:00

  • PNS6 VALUE-ASSESSMENT FRAMEWORKS: WE CANNOT ESCAPE THE ETHICAL DILEMMAS POSED BY THEIR USE

    Oct 1, 2019, 00:00

  • PAM4 ANALISE DOS CUSTOS DE TERAPIAS NUTRICIONAIS APOS ACOES DE AUDITORIA: UMA ANALISE DE DADOS DO MUNDO REAL

    Oct 1, 2019, 00:00

  • PNS58 RESULTADOS DE UM PROGRAMA DE ATENDIMENTO EM SAÚDE EM ÁREAS REMOTAS DA AMAZÔNIA OCIDENTAL BRASILEIRA

    Oct 1, 2019, 00:00

  • PCN2 EFECTIVIDAD DE LA MAMOGRAFIA EN MUJERES MENORES DE 40 AÑOS: REVISION SISTEMATICA.

    Oct 1, 2019, 00:00

  • PIN5 CUSTO COM ANTIMICROBIANOS NO TRATAMENTO DE INFECCAO MULTIRRESISTENTE AOS CARBAPENEMICOS: VISAO DE UMA OPERADORA DE SAUDE

    Oct 1, 2019, 00:00

  • PCN31 BURDEN OF DISEASE FOR ADVANCED BREAST CANCER IN MEXICO

    Oct 1, 2019, 00:00

  • PCV11 BURDEN OF STERNAL WOUND INFECTIONS FOLLOWING CORONARY ARTERY BYPASS GRAFT PROCEDURE IN SELECT COUNTRIES

    Oct 1, 2019, 00:00

  • PUK1 COST CONSEQUENCE ANALYSIS OF A REMOTE MONITORING PROGRAM TO IMPROVE CLINICAL PRACTICE OF AUTOMATED PERITONEAL DYALISIS IN COLOMBIA

    Oct 1, 2019, 00:00

  • PDB5 IMPACTO ECONOMICO DE HIPERTENSION ARTERIAL Y OBESIDAD EN PERU

    Oct 1, 2019, 00:00

  • CN1 CALIDAD DE VIDA RELACIONADA A LA SALUD Y COSTOS DEL SISTEMA DE SALUD, POR PÉRDIDA DE PRODUCTIVIDAD Y OTROS DE PACIENTES CON DIAGNOSTICO DE CÁNCER DE MAMA EN AMÉRICA LATINA Y EL CARIBE: REVISIÓN SISTEMÁTICA Y META-ANALISIS

    Oct 1, 2019, 00:00

  • PSY7 VENOUS THROMBOEMBOLISM DISEASE: DIRECT COSTS ASSOCIATED WITH ITS TREATMENT IN ARGENTINA

    Oct 1, 2019, 00:00

  • PMH4 STROKE IN BRAZIL: COST OF ILLNESS ON THE LENGTH OF SATY IN HOSPITAL

    Oct 1, 2019, 00:00

  • PIH18 EVALUATION OF INFORMATION SHARING IN CONNECTION WITH SCHOOL HEALTH ATTENDANCE AND ITS EFFECTS ON THE ATTENDANCE OF HEALTH SERVICE

    Oct 1, 2019, 00:00

  • PIN18 BURDEN OF ILLNESS OF HERPES ZOSTER IN COLOMBIA: AN OBSERVATIONAL STUDY

    Oct 1, 2019, 00:00

  • EP3 CARACTERIZACIÓN EPIDEMIOLÓGICA DE PACIENTES CON ARTRITIS REUMATOIDE ATENDIDOS EN SISTEMA GENERAL DE SEGURIDAD SOCIAL EN SALUD DE COLOMBIA.

    Oct 1, 2019, 00:00

  • CR2 IMPACTO ECONOMICO DE CANCER DE MAMA Y SU TENDENCIA AL 2030 EN EL SISTEMA DE SALUD PUBLICO DEL PERU

    Oct 1, 2019, 00:00

  • PIN21 PROFILING PURCHASE VOLUMES AND EXPENDITURES WITH DIRECT-ACTING ANTIRETROVIRALS FOR HEPATITIS C BY THE BRAZILIAN MINISTRY OF HEALTH, 2015-2018

    Oct 1, 2019, 00:00

  • PCN57 PATIENTS WITH CANCER VIEW PHYSICAL SYMPTOMS AND IMPACT OF SYMPTOMS AS IMPORTANT INFORMATION TO PROVIDE HEALTHCARE PROVIDERS ON A DAILY BASIS

    Oct 1, 2019, 00:00

  • PCN65 ANÃLISIS COMPARATIVO DE CUSTOS DE PACIENTES DE CÃNCER POR REGIÃO GEOGRÃFICA

    Oct 1, 2019, 00:00

  • PDG5 BUDGET IMPACT ANALYSIS OF CLADRIBINE IN HIGH DISEASE ACTIVITY RELAPSE REMITTING MULTIPLE SCLEROSIS IN ARGENTINA

    Oct 1, 2019, 00:00

  • PNS21 EFECTIVIDAD DE INTERVENCIONES DE EDUCACION SEXUAL EN ADOLESCENTES: REVISION DE REVISIONES

    Oct 1, 2019, 00:00

  • PND8 ANALISIS DE MINIMIZACION DE COSTOS DE TOXINA ONABOTULINICA A 100 U EN PACIENTES CON BLEFAROESPASMO Y TORTICOLIS ESPASMODICA

    Oct 1, 2019, 00:00

  • PMD6 CENTRIFUGAL VERSUS MEMBRANE THERAPEUTIC PLASMA EXCHANGE: A CHILEAN, MULTI-CENTER, COST-COMPARISON STUDY

    Oct 1, 2019, 00:00

  • PCN22 ESTUDIO DE COSTO EFECTIVIDAD DE RIBOCICLIB/LETROZOL PARA EL TRATAMIENTO DEL CANCER DE MAMA METASTASICO CON RECEPTORES DE HORMONA POSITIVO Y HER-2 NEGATIVO DESDE LA PERSPECTIVA DEL SISTEMA DE SALUD PUBLICO CHILENO

    Oct 1, 2019, 00:00

  • Copyright/Subscription

    Sep 18, 2019, 08:26

  • Valuing Health States in Russia: A First Feasibility Study

    Sep 1, 2019, 00:00

  • Editorial Board

    Sep 1, 2019, 00:00

  • Table of Contents

    Sep 1, 2019, 00:00

  • The Impact of Financial Crisis, Austerity Measures, and Bailout Agreement on Cypriots’ Health: The Memorandum Is Dead, Long Live the Memorandum

    Sep 1, 2019, 00:00

  • Requirements for a Successful Drug Launch in Small Markets: A Pilot Study in Lebanon

    Sep 1, 2019, 00:00

  • Evaluations of Morphine and Fentanyl for Mechanically Ventilated Patients With Respiratory Disorders in Intensive Care: A Systematic Review of Methodological Trends and Reporting Quality

    Sep 1, 2019, 00:00

  • The Value of a Statistical Life-Year in Sub-Saharan Africa: Evidence From a Large Population-Based Survey in Tanzania

    Sep 1, 2019, 00:00

  • Cost-Effectiveness of Docetaxel and Paclitaxel for Adjuvant Treatment of Early Breast Cancer: Adaptation of a Model-Based Economic Evaluation From the United Kingdom to South Africa

    Sep 1, 2019, 00:00

  • Factors That Predict Overall Patient Satisfaction With Oncology Hospital Care in Bulgaria

    Sep 1, 2019, 00:00

  • Cost-Effectiveness Comparison of Pneumococcal Conjugate Vaccines in Turkish Children

    Sep 1, 2019, 00:00

  • What Is the Value of Innovative Pharmaceutical Therapies in Oncology and Hematology? A Willingness-to-Pay Study in Bulgaria

    Sep 1, 2019, 00:00

  • Impact of a Collaborative Pharmaceutical Care Service Among Patients With Diabetes in an Ambulatory Care Setting in Qatar: A Multiple Time Series Study

    Sep 1, 2019, 00:00

  • Willingness-to-Accept and Willingness-to-Pay Ratios of Prevention of Mother-to-Child Transmission Services in a Nigerian Hospital: A Cross-Sectional Contingent Valuation Study

    Sep 1, 2019, 00:00

  • Cost of Healthcare Associated With Deep Vein Thrombosis in Patients Treated With Warfarin in Turkey: 2010-2013 Database Analysis of a Tertiary Care Center

    Sep 1, 2019, 00:00

  • Structural Changes in the Hungarian Healthcare System Between 2000 and 2017

    Sep 1, 2019, 00:00

  • Analysis of Direct Monthly Cost of Outpatient Hospital-Based Care for Children With Cerebral Palsy in Kano, Nigeria

    Sep 1, 2019, 00:00

  • The Cost of Managing Occupational Injuries Among Frontline Construction Workers in Ghana

    Sep 1, 2019, 00:00

  • Safety-Engineered Syringes: An Intervention to Decrease Hepatitis C Burden in Developing Countries—A Cost-Effectiveness Analysis From Egypt

    Sep 1, 2019, 00:00

  • External Reference Pricing for Pharmaceuticals—A Survey and Literature Review to Describe Best Practices for Countries With Expanding Healthcare Coverage

    Sep 1, 2019, 00:00

  • Impact of Disparities in Reimbursement Rules Between Public and Private Sectors on Accessibility to Care in Moroccan Mandatory Health Insurance: A Cross-Sectional Study

    Sep 1, 2019, 00:00

  • The Burden of Macular Diseases in Central and Eastern Europe—Implications for Healthcare Systems

    Sep 1, 2019, 00:00

  • Review of Pharmacoeconomic Studies in Russian Cancer Research: An Outside View

    Sep 1, 2019, 00:00

  • Pseudo-Generics in South Africa: A Price Comparison

    Sep 1, 2019, 00:00

  • Copyright/Subscription

    Jun 11, 2019, 09:02

  • Assessing Diabetes Distress Among Type 2 Diabetes Mellitus in Malaysia Using the Problem Areas in Diabetes Scale

    May 1, 2019, 00:00

  • Valuation of Quality Weights for EuroQol 5-Dimensional Health States With the Time Trade-Off Method in the Capital of Iran

    May 1, 2019, 00:00

  • Utility Measures in Pediatric Temporary Health States: Comparison of Prone Positioning Valuation Through 5 Assessment Tools

    May 1, 2019, 00:00

  • Revisiting Roles of Health Technology Assessment on Drug Policy in Universal Health Coverage in Thailand: Where Are We? And What Is Next?

    May 1, 2019, 00:00

  • Editorial Board

    May 1, 2019, 00:00

  • Cost-Effectiveness of Adjuvant Trastuzumab Therapy for Early Breast Cancer in Asia: A Systematic Review

    May 1, 2019, 00:00

  • Budget Impact Analysis of Rotavirus Vaccine Adoption in the Childhood Immunization Schedule of Iran

    May 1, 2019, 00:00

  • Pharmaceutical Policy Reforms to Regulate Drug Prices in the Asia Pacific Region: The Case of Australia, China, India, Malaysia, New Zealand, and South Korea

    May 1, 2019, 00:00

  • A Trial-Based Cost-Effectiveness Analysis of Bevacizumab and Chemotherapy Versus Chemotherapy Alone for Advanced Nonsquamous Non–Small-Cell Lung Cancer in China

    May 1, 2019, 00:00

  • Retraction notice

    May 1, 2019, 00:00

  • Long-Term Clinical Benefits of Canagliflozin 100 mg Versus Sulfonylurea in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin in India

    May 1, 2019, 00:00

  • Comparison of Equity Preferences for Life Expectancy Gains: A Discrete Choice Experiment Among the Japanese and Korean General Public

    May 1, 2019, 00:00

  • Comparison of EQ-5D-5L, VAS, and SF-6D in Thai Patients on Peritoneal Dialysis

    May 1, 2019, 00:00

  • From Research to Policy Implementation: Trastuzumab in Early-Stage Breast Cancer Treatment in Thailand

    May 1, 2019, 00:00

  • Stewardship as a Fundamental Challenge in Strategic Purchasing of Health Services: A Case Study of Iran

    May 1, 2019, 00:00

  • Health-Related Quality of Life of Pediatric Spinal Surgery Complications

    May 1, 2019, 00:00

  • The Cost of Hypoglycemia Associated With Type 2 Diabetes Mellitus in Taiwan

    May 1, 2019, 00:00

  • Table of Contents

    May 1, 2019, 00:00

  • Assessing the Burden of Type 2 Diabetes in China Considering the Current Status-Quo Management and Implications of Improved Management Using a Modeling Approach

    May 1, 2019, 00:00

  • Economic Evaluations of Dengue Vaccination in the Southeast Asia Region: Evidence From a Systematic Review

    May 1, 2019, 00:00

  • Health Technology Assessment and Its Use in Drug Policy in Malaysia

    May 1, 2019, 00:00

  • A Stepwise Approach to a National Hepatitis C Screening Strategy in Malaysia to Meet the WHO 2030 Targets: Proposed Strategy, Coverage, and Costs

    May 1, 2019, 00:00

  • Economics of Medical Devices in India

    May 1, 2019, 00:00

  • The Economic Burden of Chronic Obstructive Pulmonary Disease in the Asia-Pacific Region: A Systematic Review

    May 1, 2019, 00:00

  • Health Technology Assessment and Its Use in Drug Policies: Singapore

    May 1, 2019, 00:00

  • Healthcare Resource Utilization and Direct Medical Costs for Patients With Osteoporotic Fractures in China

    May 1, 2019, 00:00

  • Medication Adherence and Diabetes Self-Care Activities Among Patients With Type 2 Diabetes Mellitus

    May 1, 2019, 00:00

  • Role of Health Technology Assessment in Drug Policies: Korea

    May 1, 2019, 00:00

  • Healthcare Resource Utilization and the Cost of Care for Mucopolysaccharidosis I Patients in Iran

    May 1, 2019, 00:00

  • Copyright/Subscription

    Dec 19, 2018, 18:04

  • Copyright/Subscription

    Dec 13, 2018, 10:12

  • Good Practices and Principles in Health Technology Assessment in Latin America

    Dec 1, 2018, 00:00

  • Internal Consistency of the SF-6D as a Health Status Index in the Brazilian Urban Population

    Dec 1, 2018, 00:00

  • End-Stage Renal Disease Models in the Americas- Optimizing Resources to Achieve Better Health Outcomes

    Dec 1, 2018, 00:00

  • Cost-Effective Analysis to Incorporate Non-Drug Interventions to Increase Adherence to Antiretroviral Therapy

    Dec 1, 2018, 00:00

  • Gasto de Bolsillo en Salud y Medicamentos en Chile- Análisis Comparativo de los Periodos 1997, 2007, y 2012

    Dec 1, 2018, 00:00

  • Activity-Based Costing and Time-Driven Activity-Based Costing for Assessing the Costs of Cancer Prevention, Diagnosis, and Treatment- A Systematic Review of the Literature

    Dec 1, 2018, 00:00

  • What Is a Value Management Office? An Implementation Experience in Latin America

    Dec 1, 2018, 00:00

  • ERM for Health Care Organizations: An Economic Enterprise Risk Management Innovation Program (E2RMhealth care)

    Dec 1, 2018, 00:00

  • Engagement in a Community Physical Activity Program and Its Effects Upon the Health-Related Quality of Life of Elderly People- A Cross-Sectional Study

    Dec 1, 2018, 00:00

  • Knowledge Translation in Practice: Exploring the Potential Use of MCDA in Central America and the Caribbean

    Dec 1, 2018, 00:00

  • Cost-Effectiveness Analysis of Pneumococcal and Influenza Vaccines Administered to Children Less Than 5 Years of Age in a Low-Income District of Bogota, Colombia

    Dec 1, 2018, 00:00

  • Ingredientes Farmacéuticos Activos Potencialmente Inapropiados en Adultos Mayores- Lista IFAsPIAM- Panel de Consenso Argentino

    Dec 1, 2018, 00:00

  • Cost-Effectiveness of a Home Visit Program for Patients with Heart Failure in Brazil- Evidence from a Randomized Clinical Trial

    Dec 1, 2018, 00:00

  • Social Context and Geographic Space- An Ecological Study about Hospitalizations of Older Persons

    Dec 1, 2018, 00:00

  • Table of Contents

    Dec 1, 2018, 00:00

  • Cost-Effectiveness Analysis of Diagnosis of Duchenne/Becker Muscular Dystrophy in Colombia

    Dec 1, 2018, 00:00

  • Análisis de Costo de la Enfermedad, del Tratamiento, las Complicaciones e Intervenciones de la Hipercolesterolemia en México en 2016

    Dec 1, 2018, 00:00

  • Cost-Utility Study of PCV13 Versus PPSV23 in Adults in Chile

    Dec 1, 2018, 00:00

  • Health Care Cost for Multiple Sclerosis- The Case of a Health Insurer in Colombia

    Dec 1, 2018, 00:00

  • Economic Costs of Chikungunya Virus in Colombia

    Dec 1, 2018, 00:00

  • Editorial Board

    Dec 1, 2018, 00:00

  • Value-Based Pricing in Latin America- How Far Away Are We?

    Dec 1, 2018, 00:00

  • Electronic Version of the EQ-5D Quality-of-Life Questionnaire- Adaptation to a Brazilian Population Sample

    Dec 1, 2018, 00:00

  • Drug Utilization Studies in Latin America- A Scoping Review and Survey of Ethical Requirements

    Dec 1, 2018, 00:00

  • Inflammatory Bowel Disease in Latin America- A Systematic Review

    Dec 1, 2018, 00:00

  • Cost-Effectiveness of Combination Therapy Versus Monotherapy in Benign Prostatic Hyperplasia- A Colombian Experience

    Dec 1, 2018, 00:00

  • Postintroduction Study of Cost-Effectiveness of Pneumococcal Vaccine PCV10 from Public Sector Payer’s Perspective in the State of Santa Catarina, Brazil

    Dec 1, 2018, 00:00

  • Drug-Related Morbidity in Brazil- A Cost-of-Illness Model

    Dec 1, 2018, 00:00

  • Potentially Inappropriate Medications in Elderly Ambulatory Patients- A Comparative Study between a Primary Health Care Center and a Community Pharmacy

    Dec 1, 2018, 00:00

  • Reparación Endovascular para Aneurisma de Aorta- Revisión Panorámica Sobre su Evidencia en el Mundo y su Aplicación en Latinoamérica

    Dec 1, 2018, 00:00

  • Análisis de los Determinantes Socioeconómicos del Gasto de Bolsillo en Medicamentos en Seis Zonas Geográficas de Panamá

    Dec 1, 2018, 00:00

  • Bipolar Disorder Mixed Episodes- A Pragmatic Trial of a Public Health Treatment Effectiveness

    Dec 1, 2018, 00:00

  • Brazilian Analytical Decision Model for Cardiovascular Disease- An Adaptation of the Scottish Cardiovascular Disease Policy Model

    Dec 1, 2018, 00:00

  • Hipoglicemiantes Orais Para Diabetes Mellitus Tipo 2- Comparação de Preços no Brasil e em Outros Sistemas Universais de Saúde

    Dec 1, 2018, 00:00

  • Cost-Effectiveness of rFVIIa versus pd-aPCC in the Management of Mild to Moderate Bleeds in Pediatric Patients with Hemophilia A with Inhibitors in Mexico

    Dec 1, 2018, 00:00

  • Editorial Board

    Sep 1, 2018, 00:00

  • Comparing Use of Health Technology Assessment in Pharmaceutical Policy among Earlier and More Recent Adopters in the European Union

    Sep 1, 2018, 00:00

  • Highly Innovative Drug Program in the Czech Republic- Description and Pharmacoeconomic Results—Cost-Effectiveness and Budget Impact Analyses

    Sep 1, 2018, 00:00

  • Cost-Effectiveness of Dolutegravir as a First-Line Treatment Option in the HIV-1–Infected Treatment-Naive Patients in Russia

    Sep 1, 2018, 00:00

  • The State of Health Technology Assessment in the Ethiopian Health Sector- Learning from Recent Policy Initiatives

    Sep 1, 2018, 00:00

  • Table of Contents

    Sep 1, 2018, 00:00

  • Optimization Approach for Estimating the Required Amount of Pharmaceuticals in the Russian Federation

    Sep 1, 2018, 00:00

  • Return on Investment Analysis of Breast Cancer Screening and Downstaging in Egypt- Implications for Developing Countries

    Sep 1, 2018, 00:00

  • Drug Policy in Estonia

    Sep 1, 2018, 00:00

  • Managed Entry Agreements for Pharmaceutical Products in Middle East and North African Countries- Payer and Manufacturer Experience and Outlook

    Sep 1, 2018, 00:00

  • Drug Policy in Romania

    Sep 1, 2018, 00:00

  • Treatment Satisfaction Questionnaire for Medication- Validation of the Translated Arabic Version among Patients Undergoing Warfarin Therapy in Saudi Arabia

    Sep 1, 2018, 00:00

  • Drug Policy in the Russian Federation

    Sep 1, 2018, 00:00

  • Smoking Behavior among Jordanians- Physical, Psychological, Social, and Economic Reasons

    Sep 1, 2018, 00:00

  • Antirheumatic Medicine Prescribing Patterns and Direct Medicine Costs in the South African Private Health Sector

    Sep 1, 2018, 00:00

  • Pharmacoeconomics Evaluations of Oral Anticancer Agents- Systematic Review of Characteristics, Methodological Trends, and Reporting Quality

    Sep 1, 2018, 00:00

  • An Evidence Framework for Off-Patent Pharmaceutical Review for Health Technology Assessment in Emerging Markets

    Sep 1, 2018, 00:00

  • Drug Policy in Greece

    Sep 1, 2018, 00:00

  • Indacaterol/Glycopyrronium versus Salmeterol/Fluticasone in Patients with COPD—A Cost-Effectiveness Analysis in the Czech Republic

    Sep 1, 2018, 00:00

  • Drug Policy Research and Health Technology Assessment in Central and Eastern Europe, Western Asia, and Africa- The Interface Between Research Evidence, Policy, and Practice

    Sep 1, 2018, 00:00

  • Copyright/Subscription

    Jul 26, 2018, 13:37

  • Excess Hospitalization Expenses Attributable to Type 2 Diabetes Mellitus in Singapore

    May 1, 2018, 00:00

  • Cost-Effectiveness Analysis of the Introduction of HPV Vaccination of 9-Year-Old-Girls in Iran

    May 1, 2018, 00:00

  • Editorial Board

    May 1, 2018, 00:00

  • Recent Pricing Negotiations on Innovative Medicines Pilot in China- Experiences, Implications, and Suggestions

    May 1, 2018, 00:00

  • Possibility of Database Research as a Means of Pharmacovigilance in Japan Based on a Comparison with Sertraline Postmarketing Surveillance

    May 1, 2018, 00:00

  • The Economic Costs of Cardiovascular Disease, Diabetes Mellitus, and Associated Complications in South Asia- A Systematic Review

    May 1, 2018, 00:00

  • How Much Does Management of an Asthma-Related Event Cost in a Malaysian Suburban Hospital?

    May 1, 2018, 00:00

  • Health Technology Assessment and Its Use in Drug Policies in China

    May 1, 2018, 00:00

  • Health-Related Quality of Life of Patients with HPV-Related Cancers in Indonesia

    May 1, 2018, 00:00

  • New Drug Reimbursement and Pricing Policy in Taiwan

    May 1, 2018, 00:00

  • Modeling Possible Inclusion of Pneumococcal Conjugate Vaccine into the National Immunization Program for Infants in India

    May 1, 2018, 00:00

  • Resource Use and Cost of Treating Human Papillomavirus–Related Lesions in Japanese Women

    May 1, 2018, 00:00

  • Health-Related Quality of Life and Functional Ability of Patients with Rheumatoid Arthritis- A Study from a Tertiary Care Hospital in Thailand

    May 1, 2018, 00:00

  • Health Expenditure Growth under Single-Payer Systems- Comparing South Korea and Taiwan

    May 1, 2018, 00:00

  • Table of Contents

    May 1, 2018, 00:00

  • Evaluation of the Long-Term Impact of Improving Care for People with Type 2 Diabetes in China

    May 1, 2018, 00:00

  • Cost-Effectiveness of Warfarin Medication Therapy Adherence Clinic versus Usual Medical Clinic at Kuala Lumpur Hospital

    May 1, 2018, 00:00

  • Health Utility of Pregnant Women Living with HIV/AIDS- Prevention of Mother-to-Child Transmission of HIV (PMTCT) Programs in Yunnan Province- A Cross-Sectional Study

    May 1, 2018, 00:00

  • Evaluation of Quality of Pharmacoeconomic Studies in Asia-Pacific Region and Identification of Influencing Variables

    May 1, 2018, 00:00

  • Cost-Effectiveness Analysis of Renin-Angiotensin Aldosterone System Blockade in Progression of Chronic Kidney Disease

    May 1, 2018, 00:00

  • Cost Effectiveness of a Community-Delivered Consultation to Improve Infant Sleep Problems and Maternal Well-Being

    May 1, 2018, 00:00

  • The Cost and Quality of Life of Malaysian Type 2 Diabetes Mellitus Patients with Chronic Kidney Disease and Anemia

    May 1, 2018, 00:00

  • A Comparison of EQ-5D-3L Index Scores Using Malaysian, Singaporean, Thai, and UK Value Sets in Indonesian Cervical Cancer Patients

    May 1, 2018, 00:00

  • Cost-Effectiveness of Sorafenib Monotherapy and Selected Combination Therapy with Sorafenib in Patients with Advanced Hepatocellular Carcinoma

    May 1, 2018, 00:00

  • Cultural Adaptation and Linguistic Validation of the Beliefs about Medicines Questionnaire in Malaysia

    May 1, 2018, 00:00

  • A Review of Studies of Quality of Life for Chinese-Speaking Patients with Ischemic Heart Disease

    May 1, 2018, 00:00

  • ViHRI 2017 Reviewer Acknowledgement

    Dec 1, 2017, 00:00

  • Presenteeism, Absenteeism, and Lost Work Productivity among Depressive Patients from Five Cities of Colombia

    Dec 1, 2017, 00:00

  • Value in Health Regional Issues- PubMed Indexing and Our “Coming of Age”

    Dec 1, 2017, 00:00

  • A Cost-of-Illness Study of Patients with HIV/AIDS in Bogotá, Colombia

    Dec 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Everolimus versus Mycophenolate in Kidney Transplant Recipients Receiving No Pharmacological Prophylaxis for Cytomegalovirus Infection- A Short-Term Pharmacoeconomic Evaluation (12 Months)

    Dec 1, 2017, 00:00

  • Burden of Culture-Confirmed Pediatric Pneumococcal Pneumonia in Latin America and the Caribbean- A Systematic Review and Meta-Analysis

    Dec 1, 2017, 00:00

  • Cost Effectiveness of Dulaglutide Compared with Liraglutide and Glargine in Type 2 Diabetes Mellitus Patients in Colombia

    Dec 1, 2017, 00:00

  • HTA Implementation in Latin American Countries- Comparison of Current and Preferred Status

    Dec 1, 2017, 00:00

  • Conducting and Disseminating Epidemiological Systematic Reviews in Latin America and the Caribbean- Pitfalls and Lessons Learned

    Dec 1, 2017, 00:00

  • Copyright page

    Dec 1, 2017, 00:00

  • Costos medicos directos en pacientes con enfermedad pulmonar obstructiva Crónica en Mexico

    Dec 1, 2017, 00:00

  • Editorial Board

    Dec 1, 2017, 00:00

  • Uso de recursos y costos de hospitalizaciones por insufi ciencia card í aca- un estudio retrospective multic é ntrico en Argentina

    Dec 1, 2017, 00:00

  • ToC

    Dec 1, 2017, 00:00

  • Economic Impact of Emergency Visits due to Drug-Related Morbidity on a Brazilian Hospital

    Dec 1, 2017, 00:00

  • Single-Use Devices in Argentina- Cost Comparison Analysis of a “Re-Use” versus a “Single-Use” Policy for Trocars, Endocutters, Linear Cutters, and Harmonic Scalpels

    Dec 1, 2017, 00:00

  • Estudio de impacto presupuestal de Daclatasvir asociado a Asunaprevir desde la perspectiva del sistema de salud público chileno

    Dec 1, 2017, 00:00

  • Cost Effectiveness of Intracranial Pressure Monitoring in Pediatric Patients with Severe Traumatic Brain Injury- A Simulation Modeling Approach

    Dec 1, 2017, 00:00

  • Evaluación de tecnologías sanitarias para la toma de decisiones y la rendición de cuentas- una urgente reflexión para el sistema de salud chileno

    Dec 1, 2017, 00:00

  • Doctors Adjacent to Private Pharmacies- The New Ambulatory Care Provider for Mexican Health Care Seekers

    Dec 1, 2017, 00:00

  • Impacto del incremento del impuesto a los productos de tabaco sobre la recaudación y los precios en Panamá

    Dec 1, 2017, 00:00

  • Editorial comment on Health Technology Assessment (HTA)- Good Practices Principles. FIFARMA’s Position on HTA Processes in Latin America- The Devil Is in the Details

    Dec 1, 2017, 00:00
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10 (current)
  • »